There is uncertainty whether current strategies for providing CVD risk scores  affect CVD events .
Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher-risk people without evidence of harm .
BACKGROUND The current paradigm for cardiovascular disease ( CVD ) emphasises absolute risk assessment to guide treatment decisions in primary prevention .
Although the derivation and validation of multivariable risk assessment tools , or CVD risk scores , have attracted considerable attention , their effect on clinical outcomes is uncertain .
OBJECTIVES To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes , risk factor levels , preventive medication prescribing , and health behaviours .
A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence.
BACKGROUND Numerous studies have demonstrated the value of including pharmacists in team-based care to improve adherence to cardiovascular ( CV ) guidelines , medication adherence , and risk factor control . However , there is limited information on whether these models can be successfully implemented more widely in diverse setting s and population s. The purpose of this study is to evaluate whether a central ized , web-based cardiovascular risk service ( CVRS ) managed by clinical pharmacists will improve guideline adherence in multiple primary care medical offices with diverse geographic and patient characteristics . METHODS This study is a prospect i ve trial in 20 primary care offices stratified by the percent of under-represented minorities and then r and omized to either the CVRS intervention or usual care .  The intervention will last for 12 months and all subjects will have research visits at baseline and 12 months . The primary outcome is the difference in guideline adherence between groups . Data will also be abstract ed from the medical record at 24 months to determine if the intervention effect is sustained after it is discontinued . CONCLUSIONS Patient enrollment will continue through 2016 , with results expected in 2019 . This study will provide information on whether a distant , central ized CVRS can be implemented in large numbers of medical offices , if it is effective in diverse population s , and if there is a long-term sustained effect
There is uncertainty whether current strategies for providing CVD risk scores  affect CVD events .
Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher-risk people without evidence of harm .
BACKGROUND The current paradigm for cardiovascular disease ( CVD ) emphasises absolute risk assessment to guide treatment decisions in primary prevention .
Although the derivation and validation of multivariable risk assessment tools , or CVD risk scores , have attracted considerable attention , their effect on clinical outcomes is uncertain .
OBJECTIVES To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes , risk factor levels , preventive medication prescribing , and health behaviours .